Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Contents Vol. 17, 1995

Publikováno v: Developmental Neuroscience. 17:371-373

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c09569912352e45107891e757e3805d1
https://doi.org/10.1159/000111309

Zobrazit plný text záznamu

444 SVR FOR CONTROLLED-RELEASE INTERFERON ALPHA-2B (CR2B) +RIBAVIRIN COMPARED TO PEGYLATED INTERFERON ALPHA-2B (PEG2B) +RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 (G1) HEPATITIS C: FINAL RESULTS FROM SELECT-2

Autor: Zahary Krastev, W.A. Long, K. Tchernev, D. Takov, R. Mehra, Zobair M. Younossi, A. Rigney, E.J. Lawitz

Publikováno v: Journal of Hepatology. 54:S180-S181

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a05d038840ce603a3c98fbc758a303fd
https://doi.org/10.1016/s0168-8278(11)60446-7

Zobrazit plný text záznamu

446 TIMING AND FREQUENCY OF DEPRESSION DURING HCV-TREATMENT WITH CONTROLLED-RELEASE-IFNA2B (CR2B) VS. PEGYLATED-IFNA2B (PEG2B): RESULTS FROM SELECT-2, A RANDOMIZED-OPEN-LABEL-72-WEEK-COMPARISON IN 116 TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 HCV

Autor: E.J. Lawitz, W.A. Long, P. Mehra, A. Rigney, D. Takov, Zobair M. Younossi, Reem Ghalib, R. Balabanska, S. Stoinov, Zahary Krastev, K. Tchernev, I. Kotsev

Publikováno v: Journal of Hepatology. 54:S181-S182

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f4783ca7aab8b33060b0d88542e8b473
https://doi.org/10.1016/s0168-8278(11)60448-0

Zobrazit plný text záznamu

Pre- and postnatal effects of chronic maternal hypoxia on substance-P immunoreactivity in rabbit brainstem regions

Autor: W.A. Long, Melissa P. Wasserstein, J.L. Gingras, T. Segreti

Publikováno v: Developmental neuroscience. 17(5-6)

The effect of chronic maternal hypoxia on substance-P immunoreactivity (SPI) was examined in brainstem regions of fetal (gestational day E-28), neonatal (postnatal days 3, 7, 14, 21), and adult rabbits. Time-dated pregnant rabbit does were housed in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aed36b402964fbf6f54c4a051da5d62f
https://pubmed.ncbi.nlm.nih.gov/8829924

Zobrazit plný text záznamu

58 RANDOMIZED, OPEN-LABEL, 12-WEEK COMPARISON OF CONTROLLED-RELEASE INTERFERON ALPHA2B +RIBAVRIN VS. PEGYLATED-INTERFERON ALPHA2B +RIBAVRIN IN TREATMENT-NAIVE GENOTYPE1 HEPATITIS C: 4 WEEK RESULTS FROM 480STUDY (PANEL A)

Autor: B. Vladimirov, W.A. Long, D. Nikolovska, A. Rigney, Iskren Kotzev, F.A. Caruntu, I.G. Diaconescu, M. Voiculescu, K. Tchernev, Zahary Krastev

Publikováno v: Journal of Hepatology. 52:S27

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5226ba4686efcf4fbbdaa611fc362176
https://doi.org/10.1016/s0168-8278(10)60060-8

Zobrazit plný text záznamu

2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPARISON IN 133 PATIENTS

Autor: R. Balabanska, Eli Zuckerman, Rifaat Safadi, Zahary Krastev, N. Assy, Zobair M. Younossi, Ran Tur-Kaspa, E.J. Lawitz, S. Stoynov, Reem Ghalib, W.A. Long, Iskren Kotzev, K. Tchernev, D. Takov, Yoav Lurie, A. Rigney

Publikováno v: Journal of Hepatology. 52:S467

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eb0f589f070a08877e5fac496ffba5c0
https://doi.org/10.1016/s0168-8278(10)61201-9

Zobrazit plný text záznamu

272 EARLY VIRAL RESPONSE OF CONTROLLED-RELEASE INTERFERON ALPHA2B AND RIBAVIRIN VS. PEGYLATED-INTERFERON ALPHA2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE1 HEPATITIS C: 12 WEEK RESULTS (SELECT-2 TRIAL)

Autor: Zahary Krastev, A. Rigney, P. Mehra, E.J. Lawitz, D. Takov, W.A. Long, Zobair M. Younossi, K. Tchernev

Publikováno v: Journal of Hepatology. 52:S114

Aims: Recently, several clinical trials analyzed if extended duration of treatment with pegylated interferon-alfa and ribavirin over 48 weeks can improve sustained virologic response (SVR) rates in HCV genotype 1-infected patients with slow virologic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::00d2f792dd493880a8fd93f582367aa6
https://doi.org/10.1016/s0168-8278(10)60274-7

Zobrazit plný text záznamu

628 RANDOMIZED TRIAL COMPARING SYSTEMIC AND LOCAL REACTIONS TO CONTROLLED-RELEASE INTERFERON ALPHA2B AND PEGYLATED-INTERFERON ALPHA2B IN HEPATITIS C PATIENTS WHO FAILED PRIOR TREATMENT

Autor: W.A. Long, Andrew J. Muir, Reem Ghalib, Mitchell L. Shiffman, Zobair M. Younossi, S.C. Gordon, E.J. Lawitz, John G. McHutchison

Publikováno v: Journal of Hepatology. 50:S231

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ade38f338df7553226e557d820cc01fb
https://doi.org/10.1016/s0168-8278(09)60630-9

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání